MX2007007211A - Procedimiento de fabricacion de salicilamidas n-sustituidas. - Google Patents
Procedimiento de fabricacion de salicilamidas n-sustituidas.Info
- Publication number
- MX2007007211A MX2007007211A MX2007007211A MX2007007211A MX2007007211A MX 2007007211 A MX2007007211 A MX 2007007211A MX 2007007211 A MX2007007211 A MX 2007007211A MX 2007007211 A MX2007007211 A MX 2007007211A MX 2007007211 A MX2007007211 A MX 2007007211A
- Authority
- MX
- Mexico
- Prior art keywords
- manufacture process
- substituted salicylamides
- salicylamides
- substituted
- preparing
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- SKZKKFZAGNVIMN-UHFFFAOYSA-N Salicilamide Chemical class NC(=O)C1=CC=CC=C1O SKZKKFZAGNVIMN-UHFFFAOYSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- XRTHAPZDZPADIL-UHFFFAOYSA-N 8-[(5-chloro-2-hydroxybenzoyl)amino]octanoic acid Chemical compound OC(=O)CCCCCCCNC(=O)C1=CC(Cl)=CC=C1O XRTHAPZDZPADIL-UHFFFAOYSA-N 0.000 abstract 2
- -1 N-substituted salicylamides Chemical class 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- BWAUQTFFVCLSOS-UHFFFAOYSA-N sodiosodium hydrate Chemical compound O.[Na].[Na] BWAUQTFFVCLSOS-UHFFFAOYSA-N 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
- C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0427603.6A GB0427603D0 (en) | 2004-12-16 | 2004-12-16 | Organic compounds |
| PCT/EP2005/013454 WO2006063821A1 (en) | 2004-12-16 | 2005-12-14 | Manufacture process of n-substituted salicylamides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2007007211A true MX2007007211A (es) | 2007-08-15 |
Family
ID=34090175
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007007211A MX2007007211A (es) | 2004-12-16 | 2005-12-14 | Procedimiento de fabricacion de salicilamidas n-sustituidas. |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US8461385B2 (enExample) |
| EP (2) | EP2955171A1 (enExample) |
| JP (1) | JP5224816B2 (enExample) |
| KR (1) | KR101287233B1 (enExample) |
| CN (1) | CN101080384B (enExample) |
| AR (1) | AR055007A1 (enExample) |
| AU (1) | AU2005315850B2 (enExample) |
| BR (1) | BRPI0519327A2 (enExample) |
| CA (1) | CA2587213C (enExample) |
| ES (1) | ES2547349T3 (enExample) |
| GB (1) | GB0427603D0 (enExample) |
| GT (1) | GT200500353A (enExample) |
| IL (1) | IL183366A0 (enExample) |
| MA (1) | MA29092B1 (enExample) |
| MX (1) | MX2007007211A (enExample) |
| NO (1) | NO338969B1 (enExample) |
| PE (1) | PE20060740A1 (enExample) |
| PL (1) | PL1838664T3 (enExample) |
| PT (1) | PT1838664E (enExample) |
| RU (1) | RU2404158C2 (enExample) |
| TN (1) | TNSN07229A1 (enExample) |
| TW (1) | TW200635880A (enExample) |
| WO (1) | WO2006063821A1 (enExample) |
| ZA (1) | ZA200703826B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101627011A (zh) * | 2005-09-19 | 2010-01-13 | 爱密斯菲尔科技公司 | N-(5-氯水杨酰基)-8-氨基辛酸的二钠盐的晶形 |
| PL2215047T3 (pl) | 2007-11-02 | 2014-05-30 | Emisphere Tech Inc | Sposób leczenia niedoborów witaminy b12 |
| CN109473182B (zh) * | 2018-11-12 | 2021-10-19 | 北京北排科技有限公司 | 一种基于深度信念网络的mbr膜透水率智能检测方法 |
| CN113795482A (zh) * | 2019-05-20 | 2021-12-14 | 广州龙沙制药有限公司 | 用于制备卡沙兰的方法 |
| CN115260116B (zh) * | 2022-08-19 | 2024-04-12 | 株洲壹诺生物技术有限公司 | 8-(2-羟基苯甲酰胺基)辛酸钠及苯并噁嗪-2,4-二酮和8-溴辛酸乙酯的制法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU382610A1 (ru) * | 1968-07-08 | 1973-05-25 | Способ получения амидов карбоновых кислот | |
| NZ534409A (en) | 1999-04-05 | 2006-03-31 | Emisphere Tech Inc | Disodium salts, monohydrates, and ethanol solvates for delivering active agents |
| CZ20014637A3 (cs) * | 1999-06-25 | 2002-04-17 | The Institutes For Pharmaceutical Discovery, Llc | Substituované fenoxyoctové kyseliny |
| JP4799794B2 (ja) * | 2000-03-21 | 2011-10-26 | エミスフェアー・テクノロジーズ・インク | ジカルボキシル化中間体を介してアルキル化サリチルアミドを調製する方法。 |
| AU2001275231A1 (en) * | 2000-06-02 | 2001-12-11 | Emisphere Technologies, Inc. | Method of preparing salicylamides |
| UA80248C2 (en) * | 2000-06-29 | 2007-09-10 | Compounds and compositions for delivering active agents | |
| DE60134245D1 (de) * | 2000-09-06 | 2008-07-10 | Emisphere Tech Inc | (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten |
| US7049283B2 (en) | 2000-12-06 | 2006-05-23 | Novartis Ag | Pharmaceutical compositions for the oral delivery of pharmacologically active agents |
| CA2471144C (en) * | 2002-01-09 | 2011-06-07 | Emisphere Technologies, Inc. | Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate |
| CN1332711C (zh) * | 2002-02-20 | 2007-08-22 | 埃米球科技有限公司 | 施用glp－1分子的方法 |
| US20050054557A1 (en) * | 2002-05-09 | 2005-03-10 | Goldberg Michael M. | Compositions for delivering parathyroid hormone and calcitonin |
-
2004
- 2004-12-16 GB GBGB0427603.6A patent/GB0427603D0/en not_active Ceased
-
2005
- 2005-12-02 GT GT200500353A patent/GT200500353A/es unknown
- 2005-12-14 ES ES05818421.9T patent/ES2547349T3/es not_active Expired - Lifetime
- 2005-12-14 US US11/721,817 patent/US8461385B2/en not_active Expired - Fee Related
- 2005-12-14 KR KR1020077013580A patent/KR101287233B1/ko not_active Expired - Fee Related
- 2005-12-14 WO PCT/EP2005/013454 patent/WO2006063821A1/en not_active Ceased
- 2005-12-14 BR BRPI0519327-3A patent/BRPI0519327A2/pt not_active Application Discontinuation
- 2005-12-14 RU RU2007126972/04A patent/RU2404158C2/ru not_active IP Right Cessation
- 2005-12-14 MX MX2007007211A patent/MX2007007211A/es active IP Right Grant
- 2005-12-14 EP EP15170908.6A patent/EP2955171A1/en not_active Withdrawn
- 2005-12-14 PL PL05818421T patent/PL1838664T3/pl unknown
- 2005-12-14 AU AU2005315850A patent/AU2005315850B2/en not_active Ceased
- 2005-12-14 JP JP2007545942A patent/JP5224816B2/ja not_active Expired - Fee Related
- 2005-12-14 CN CN2005800431247A patent/CN101080384B/zh not_active Expired - Fee Related
- 2005-12-14 PT PT58184219T patent/PT1838664E/pt unknown
- 2005-12-14 EP EP05818421.9A patent/EP1838664B1/en not_active Expired - Lifetime
- 2005-12-14 PE PE2005001448A patent/PE20060740A1/es not_active Application Discontinuation
- 2005-12-14 CA CA2587213A patent/CA2587213C/en not_active Expired - Fee Related
- 2005-12-14 AR ARP050105245A patent/AR055007A1/es not_active Application Discontinuation
- 2005-12-15 TW TW094144576A patent/TW200635880A/zh unknown
-
2007
- 2007-05-11 ZA ZA200703826A patent/ZA200703826B/xx unknown
- 2007-05-21 IL IL183366A patent/IL183366A0/en unknown
- 2007-06-11 MA MA29983A patent/MA29092B1/fr unknown
- 2007-06-15 TN TNP2007000229A patent/TNSN07229A1/fr unknown
- 2007-07-09 NO NO20073548A patent/NO338969B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008524142A (ja) | 2008-07-10 |
| WO2006063821A1 (en) | 2006-06-22 |
| EP2955171A1 (en) | 2015-12-16 |
| EP1838664A1 (en) | 2007-10-03 |
| EP1838664B1 (en) | 2015-07-15 |
| JP5224816B2 (ja) | 2013-07-03 |
| PT1838664E (pt) | 2015-10-16 |
| ES2547349T3 (es) | 2015-10-05 |
| AU2005315850A1 (en) | 2006-06-22 |
| MA29092B1 (fr) | 2007-12-03 |
| CA2587213A1 (en) | 2006-06-22 |
| PE20060740A1 (es) | 2006-09-04 |
| KR101287233B1 (ko) | 2013-07-17 |
| US20090253811A1 (en) | 2009-10-08 |
| RU2007126972A (ru) | 2009-01-27 |
| AU2005315850B2 (en) | 2009-11-05 |
| TW200635880A (en) | 2006-10-16 |
| AR055007A1 (es) | 2007-08-01 |
| KR20070086276A (ko) | 2007-08-27 |
| CN101080384B (zh) | 2011-06-15 |
| IL183366A0 (en) | 2007-09-20 |
| NO338969B1 (no) | 2016-11-07 |
| GB0427603D0 (en) | 2005-01-19 |
| CA2587213C (en) | 2015-05-19 |
| NO20073548L (no) | 2007-09-17 |
| US8461385B2 (en) | 2013-06-11 |
| ZA200703826B (en) | 2008-08-27 |
| CN101080384A (zh) | 2007-11-28 |
| BRPI0519327A2 (pt) | 2009-01-13 |
| PL1838664T3 (pl) | 2016-04-29 |
| RU2404158C2 (ru) | 2010-11-20 |
| TNSN07229A1 (en) | 2008-11-21 |
| GT200500353A (es) | 2006-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP095220A (es) | Derivados de n-fenil-2-pirimidin-amina | |
| TNSN07228A1 (en) | Manufacture process of organic compounds | |
| DOP2001000238A (es) | Proceso para la fabricacion de acidos n-aril-antrani- licos y sus derivados (process for making-aryl- anthranilic acids and their) | |
| IS6069A (is) | N-cýanómetýlamíð sem próteasalatar | |
| IS2582B (is) | Afleiður af N-(arýlsúlfónýl)beta-amínósýrum sem samanstanda af setnum amínómetýl hópi, aðferð til framleiðslu á afleiðum og lyfjafræðilegar samsetningar sem innihalda þær | |
| NO20012921L (no) | Fenylglycin-derivater | |
| TNSN07229A1 (en) | Manufacture process of n-substituted salicylamides | |
| MXPA03000510A (es) | Sales estables de acido o-acetilsalicilico con aminoacidos basicos. | |
| HN2003000038A (es) | Esteres hidroxamato de acido n-(4-fenil-sustituido)-antranilico | |
| ZA202211321B (en) | N,n'-guanidinodiacetic acid | |
| IL189015A0 (en) | Crystalline forms of the di-sodium salt of n-(5-chlorosalicyloyl)-8-aminocaprylic acid | |
| DK1341749T3 (da) | Fremgangsmåde til fremstilling af gabapentin | |
| MY142270A (en) | New process for the synthesis of (7-methoxy-1-naphthyl)acetonitrile and application in the synthesis of agomelatine | |
| MXPA05003355A (es) | Composicion farmaceutica que comprende semihidrato de metansulfonato de sibutramina cristalino. | |
| CY1112047T1 (el) | Διαδικασια για την παρασκευη γκαμπαπεντινης | |
| EP1541546A4 (en) | AMINO ACID ESTER SALT CRYSTAL AND PROCESS FOR PRODUCING THE SAME | |
| BRPI0406970A (pt) | Modificação cristalina de um complexo de manganês | |
| PL1845966T3 (pl) | Farmaceutyczny preparat do zastosowania w leczeniu lub profilaktyce chorób nowotworowych | |
| MXPA06000995A (es) | Amidas novedosas de acido indolil-3-glioxilico sustituidas en el atomo de n, uso de las mismas como medicamento y metodo para la produccion de las mismas. | |
| FI20011892A0 (fi) | Menetelmä entakaponia, levodopaa ja karbidopaa sisältävän farmaseuttisen koostumuksen valmistamiseksi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |